Market Overview

UPDATE: Furex Pharmaceuticals Shares Rise 78% Premarket on Positive Top-Line Results from Two Pivotal Phase III Clinical Trials of Eluxadoline for IBS-d

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: News Guidance Pre-Market Outlook Movers

 

Related Articles (FURX)